Flagship Harbor Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,282
| Closed | -$237K | – | 753 |
|
|
2024
Q4 | $237K | Buy |
+1,282
| New | +$237K | 0.01% | 643 |
|
|
2024
Q1 | $445K | Sell |
1,642
-150
| -8% | -$40.6K | 0.03% | 414 |
|
|
2023
Q4 | $424K | Sell |
1,792
-20
| -1% | -$4.73K | 0.03% | 397 |
|
|
2023
Q3 | $355K | Hold |
1,812
| – | – | 0.03% | 427 |
|
|
2023
Q2 | $381K | Buy |
1,812
+591
| +48% | +$124K | 0.03% | 418 |
|
|
2023
Q1 | $246K | Buy |
1,221
+70
| +6% | +$14.1K | 0.02% | 537 |
|
|
2022
Q4 | $251K | Buy |
+1,151
| New | +$251K | 0.03% | 518 |
|
|
2020
Q4 | – | Sell |
-348
| Closed | -$78K | – | 764 |
|
|
2020
Q3 | $78K | Hold |
348
| – | – | 0.01% | 727 |
|
|
2020
Q2 | $60K | Buy |
348
+30
| +9% | +$5.17K | 0.01% | 796 |
|
|
2020
Q1 | $40K | Hold |
318
| – | – | 0.01% | 816 |
|
|
2019
Q4 | $49K | Hold |
318
| – | – | 0.01% | 810 |
|
|
2019
Q3 | $42K | Hold |
318
| – | – | 0.01% | 823 |
|
|
2019
Q2 | $45K | Buy |
318
+181
| +132% | +$25.6K | 0.01% | 784 |
|
|
2019
Q1 | $19K | Hold |
137
| – | – | ﹤0.01% | 1093 |
|
|
2018
Q4 | $15K | Hold |
137
| – | – | ﹤0.01% | 1105 |
|
|
2018
Q3 | $18K | Sell |
137
-15
| -10% | -$1.97K | ﹤0.01% | 1147 |
|
|
2018
Q2 | $17K | Buy |
+152
| New | +$17K | ﹤0.01% | 1156 |
|